← FDA Drug Approvals (Drugs@FDA)

OLOPATADINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2024-07-12

Drug application

FDA Application #

ANDA209015

Application type

Abbreviated New Drug Application (Generic)

Brand name

OLOPATADINE HYDROCHLORIDE

Generic name

Olopatadine Hydrochloride

Active ingredients

OLOPATADINE HYDROCHLORIDE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

None (Tentative Approval)

Sponsor

APOTEX

First approval

2024-07-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown